Mayinglong Hemorrhoids
FDA Label NDC 68511-993

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Mayinglong Pharmaceutical Group Co Ltd for the product Mayinglong Hemorrhoids (NDC 68511-993). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warning, stop use, direction, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Zinc Oxide 0.8g Astrigent

Petrolatum 7.85g Protectant

Purpose

Astrigent

Protectant

Protectant

Uses

helps relieve the local itching and discomfort associated with hemorrhoids

temporarily shrinks hemorrhoidal tissue and relieves burning

temporarily provides a coating for relief of anorectal discomforts

temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Warning

For external and /or intrarectal use only. Not for oral use.

Apply it carfully during pregnancy.

Keep this and all drugs out of reach of children.

Stop Use

bleeding occurs

condition worses or does not improve within 7 days

introduction of applicator into the rectum causes additional pain

Direction

Apply properly onto anus or apply on affected areas twice a day.

Other Information

Store at 20-25 degree Centigrade (68-77 degree Fahrenheit)

Inactive Ingredients

Musk Ketone

Pearl (Hyriopsis Cumming II)

Borneol

Sodium Borate

* Please review the disclaimer below.